Home › NDC Lookup › Ingredients › Lidocaine Hcl › 70000-0098-01
Leader Lidocaine HCL 4 g/100g Cream, 1 bottle — NDC 70000-0098-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Leader Lidocaine HCL 4 g/100g Cream, 1 bottle — NDC 70000-0098-1 (Billing 70000-0098-01)

by Cardinal Health · 1 BOTTLE, PLASTIC in 1 CARTON / 76.5 g in 1 BOTTLE, PLASTIC

This is a package of 1 bottle of Leader Lidocaine HCL 4 g/100g Cream from Cardinal Health, marketed since Oct 2021 and currently FDA-listed; retail pharmacies pay about $0.0521 per g (NADAC). It is this product's only package size.

NDC 70000-0098-01
🏷️ FDA NDC (as labeled) 70000-0098-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0098-1
Product NDC 70000-0098
11-digit billing NDC 70000009801
NCPDP billing unit GM — per gram (weight)
RxCUI 1010895
UNII V13007Z41A
UPC 0096295141016
Application # M017
SPL Set ID cea6bd2d-a265-1209-e053-2995a90ab0a5
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-10-18
Route TOPICAL
Dosage form CREAM
Substance LIDOCAINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90850060103735
GCN Seq No 075061
GCN 39982
HICL code 001478
Ingredient (HICL) Lidocaine Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5H
Therapeutic class — specific (HIC3) Topical Local Anesthetics
AHFS code 72:00.00.00
AHFS class Local Anesthetics
FDB label name LIDOCAINE HCL 4% CREAM
FDB brand name Lidocaine Hcl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 075061
  • GCN: 39982
  • GPI-14 (Medi-Span): 90850060103735
  • HICL (First Databank): 001478
  • AHFS class code: 72:00.00.00
  • RxCUI (RxNorm): 1010895
Why two NDCs? The FDA registers this code as 70000-0098-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0098-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiarrhythmic class.

Pharmacologic class Antiarrhythmic, Amide Local Anesthetic
Drug family (ATC) Antiarrhythmics, class Ib, Local anesthetics, Anesthetics for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name LIDOCAINE HCL 4% CREAM Ingredient Lidocaine Hcl
📗 Our plain-language guide HelloPharmacist
  • Lidocaine numbs the area where it is used. Clinicians inject it for procedures. Skin products are used for pain, itching, minor burns, insect bites, hemorrhoid discomfort, and in s...
  • Clean and dry the skin first, then apply as your product’s directions say. Wash your hands afterward. Don’t exceed the number of uses on the label. Ask a doctor before using a prod...
  • No. Heat can increase how much lidocaine your body absorbs. Don’t bandage tightly either. Also avoid using other topical pain products at the same time.
  • Can I use a heating pad with a lidocaine patch?
📖 Read our full Lidocaine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.052 $3.99 / 76.5 g
Medicaid paysCMS SDUD · 12 mo $0.1122 $8.58 / 76.5 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Jul 2022 Feb 2024 Apr 2026 Sep 2026 $0.053 $0.042
▲ Up 25% over the last 16 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0098-01 You're viewing this Main listing 1 BOTTLE, PLASTIC in 1 CARTON / 76.5 g in 1 BOTTLE, PLASTIC 2021-10-18 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GNP Lidocaine Maximum Strength 4 g/100g 46122-0614-10 AMERISOURCE 1 bottle $0.052 — Availability likely —
Leader 4 g/100gthis 70000-0098-01 Cardinal 1 bottle $0.052 — Availability likely —
Lidocaine HCL 4 g/100g 87137-0101-07 Matthias 1 bottle $0.052 — Availability likely —
Pain and Itch Relief 4% Lidocaine .04 g/40g 00363-3001-24 Walgreens 1 tube — — FDA listed —
Walgreens Pain Relieving Cream 4 g/100g 00363-3037-02 Walgreens 76.5 g — — FDA listed —
Mentholatum Lidocaine Heat 40 mg/mL 10742-8386-01 The 1 bottle — — FDA listed —
Signature Care Lidocaine Cream 40 mg/g 21130-0544-27 Better 1 bottle — — FDA listed —
Kroger Analgesic Analgesic 40 mg/g 30142-0260-01 THE 1 bottle — — FDA listed —
TopCare Pain Relieving Analgesic 40 mg/g 36800-0470-01 Topco 1 bottle — — FDA listed —
Gold Bond Medicated Pain and Itch Relief 4 g/100g 41167-0529-00 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine with Rosemary and Mint 4 g/100g 41167-0565-00 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine with Eucalyptus Essential Oil 4 g/100g 41167-0566-00 Chattem, 1 tube — — FDA listed —
Aspercreme with Lidocaine Pain Relieving Creme 4 g/100g 41167-0582-01 Chattem, 1 bottle — — FDA listed —
Aspercreme with Lidocaine Foot Pain Creme 4 g/100g 41167-0586-02 Chattem, 1 bottle — — FDA listed —
Aspercreme with Lidocaine Pain Relieving Creme 4 g/100g 41167-0587-07 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine Foot (Diabetic) 4 g/100g 41167-0597-00 Chattem, 1 bottle — — FDA listed —
LidoStat 40 mg/g 44577-0704-02 Clinical 1 tube — — FDA listed —
Equate Pain Relief Cream 4 mg/100mL 49035-0634-97 Walmart, 74 ml — — FDA listed —
Equate Pain Relieving Cream Lidocaine 40 mg/g 49035-0860-01 Wal-Mart 1 bottle — — FDA listed —
CVS Lidocaine Pain Relief Cream 40 mg/g 51316-0379-43 CVS 1 bottle — — FDA listed —
Launch Medical 4 g/100mL 54723-0018-01 Sambria 30 ml — — FDA listed —
BeardedMoney 4 g/100g 54723-0032-01 Sambria 15 g — — FDA listed —
NeuroMed 7 Topical Pain Relief 4 g/100g 54723-0175-22 Sambria 1 tube — — FDA listed —
DG Health Pain Relieving 40 mg/g 55910-0759-01 DOLGENCORP, 1 bottle — — FDA listed —
T-Relief Lidocaine HCL 4% 3.4 g/85g 62795-6050-07 Medinatura 85 g — — FDA listed —
QC Lidocaine Maximum Strength 4 g/100g 63868-0956-01 Chain 1 bottle — — FDA listed —
Pain Itch Relief 4 g/100g 69396-0120-17 Trifecta 1 bottle — — FDA listed —
Lidocaine 4 Percent 4 g/100g 69420-6262-01 SA3, 120 g — — FDA listed —
CVS Health Lidocaine Cream 40 mg/g 69842-0814-77 CVS 1 bottle — — FDA listed —
CVS Lidocaine Maximum Strength 4 g/100g 69842-0921-49 CVS 1 bottle — — FDA listed —
CVS Health Lidocaine Pain Relief 40 mg/g 69842-0980-01 CVS 1 bottle — — FDA listed —
BENGAY Tropical Jasmine 40 mg/g 69968-0614-03 Kenvue 1 tube — — FDA listed —
NumbR-X 4 g/100g 70171-0001-01 Prodigy 1 jar — — FDA listed —
Dr Lido 4 g/100g 70171-0002-01 Prodigy 1 jar — — FDA listed —
Inked Inspired 4 g/100g 70171-0003-01 Prodigy 1 jar — — FDA listed —
Dr Tatty Numbing 4 g/100g 70171-0020-01 Prodigy 1 jar — — FDA listed —
TattooGirl Numbing 4 g/100g 70171-0021-01 Prodigy 1 tube — — FDA listed —
InkKulture Numbing 4 g/100g 70171-0022-01 Prodigy 1 tube — — FDA listed —
Inkorporated Numbing 4 g/100g 70171-0028-01 Prodigy 1 jar — — FDA listed —
Ink Scribd Numbing 4 g/100g 70171-0029-01 Prodigy 1 jar — — FDA listed —
LidoPlus Pain Relief 40 mg/mL 70372-0723-01 Centura 1 tube — — FDA listed —
TheraCare Pain Relieving Lidocaine Cream 4 g/100g 71101-0056-01 Veridian 1 bottle — — FDA listed —
TheraCare Pain Relieving Lidocaine Cream 4 g/100g 71101-0057-01 Veridian 1 bottle — — FDA listed —
HealthWise 4% Lidocaine Cream 2.7 oz 4 g/100g 71101-0102-01 Veridian 1 bottle — — FDA listed —
HealthWise Pain Relief Lidocaine 4 g/100g 71101-0107-47 Veridian 1 bottle — — FDA listed —
HealthWise 4% Lidocaine Cream 4 g/100g 71101-0919-27 Veridian 1 bottle — — FDA listed —
TheraCare 4% Lidocaine Cream 4 g/100g 71101-0930-01 Veridian 1 bottle — — FDA listed —
HealthWise Pain Relief Cream with Lidocaine 4 g/100g 71101-0932-01 Veridian 1 bottle — — FDA listed —
Lidocaine HCl 4 Percent 4 g/100g 71436-0026-01 ARI 120 g — — FDA listed —
Lidozall Plus 4 g/100g 72835-0114-15 V2 15 packets — — FDA listed —
Lidozall Pro 4 g/100g 72835-0445-05 V2 5 packets — — FDA listed —
DCH Pain Relief 4 g/100g 72839-0361-02 Derma 76.5 g — — FDA listed —
SUGAR BRANDS Rescue Pain Relief and Recovery 40 mg/mL 73313-0075-04 Sugar 118 ml — — FDA listed —
Lidocaine HCI 40 mg/g 73352-0204-60 Trifluent 30 g — — FDA listed —
LidoGuard 4 g/100g 73492-0272-30 ALAINA 1 tube — — FDA listed —
TopCare Pain Relieving Cream 40 mg/g 76162-0291-02 Topco 1 bottle — — FDA listed —
Sting Master 40 mg/g 80324-0078-00 Les 1 jar — — FDA listed —
Lidocaine Pain Relief Roll-On 4 g/100mL 82645-0013-97 Pharma 1 bottle — — FDA listed —
Westlake Lidocaine 4 g/100g 82895-0717-50 Westlake 1 bottle — — FDA listed —
Westlake Outdoor Pain and Itch Relieving 40 mg/g 82895-0718-50 WESTLAKE 49 g — — FDA listed —
Lidocore 3.1 g/76.5g 82944-0201-02 iON 1 bottle — — FDA listed —
Gold Bond Maximum Strength Foot Pain Relief 4 g/100g 84714-0427-06 Gold 1 bottle — — FDA listed —
Gold Bond Medicated Pain and Itch Relief 4 g/100g 84714-0529-00 Gold 1 bottle — — FDA listed —
Ikonik Tonik 4 g/100mL 85132-0001-30 IKONIK 1 tube — — FDA listed —
LidoGuard 4 g/100g 85231-0200-30 ViolaCare, 1 tube — — FDA listed —
Alcemiste 4 g/100mL 87087-0001-01 Price 1 jar — — FDA listed —
Tattoo Numbx Numbing Pain Relieving 40 mg/mL 87460-0905-00 Scyberco 1 tube — — FDA listed —
Do Me Delay 4 g/100g 70171-0051-01 Prodigy 1 tube — — FDA listed —
Burn Relief Aloe 4 g/100g 80551-0001-03 Acutens 113 g — — FDA listed —
Pure Primal Delay 4 g/100g 70171-0060-01 Prodigy 1 tube — — FDA listed —
Mirakel Pain Relief Roll-On 4 g/100g 78589-0257-03 Sanvio, 85 g — — FDA listed —
Blt 2 4 g/100g 70372-0728-01 CENTURA 5 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Oct 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII ZY81Z83H0X
    Aloe vera leaf is a plant extract derived from the aloe plant. It is used in medicines as a natural moisturizer and skin-soothing agent in topical formulations.
  • UNII LU49E6626Q
    A synthetic organic compound used as a pH buffer and neutralizing agent in medicines. It helps maintain the proper acidity level in liquid formulations to improve stability and comfort.
  • UNII Q95M2P1KJL
    A silicone-based ingredient that acts as a lubricant and glidant. It helps the tablet or capsule move smoothly through manufacturing equipment and improves powder flow during production.
  • UNII 921FTA1500
    A synthetic compound derived from cetyl alcohol and ethylene oxide. It acts as an emulsifier and solubilizer to help blend oil and water components together in liquid formulations.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII 2V6E5WN99N
    A lipid compound made from fatty acids, used as an emulsifier and stabilizer in medicines to help mix oil and water-based ingredients and keep them from separating.
  • UNII 2Y53S6ATLU
    Dimethicone 350 is a silicone-based oil. It works as a lubricant and anti-foaming agent to help the medicine flow smoothly during manufacturing and reduce unwanted bubbles in the final product.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII FCZ5MH785I
    A waxy substance made from glycerin and stearic acid. It works as an emulsifier to help mix oil and water ingredients together, and as a thickener to give the medicine its proper texture and consistency.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 53J3F32P58
    A synthetic detergent derived from stearic acid, a fatty substance. It helps dissolve or distribute oil-based ingredients evenly throughout the medicine, acting as an emulsifier and solubilizer in tablets and capsules.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

14 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesacrylates/C10-30 alkyl acrylate crosspolymer, aloe barbadensis (aloe vera) leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, edetate disodium, ethylhexylglycerin, glyceryl monostearate, methylparaben, purified water, SD alcohol 40, steareth-21

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCardinal Health
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedOct 2021
Product typeHuman Otc Drug
Portfolio84 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 19 words ▾

Uses temporarily relieves pain and itching due to: minor burns sunburn minor cuts scrapes insect bites minor skin irritations

⏱️ Dosage and Administration 27 words ▾

Directions adults and children 2 years and over: apply to affected area not more than 3 to 4 times daily children under 2 years: ask a doctor

⚠️ Warnings 73 words ▾

Warnings For external use only Do not use in large quantities, particularly over raw surfaces or blistered areas When using this product do not get into eyes Stop use and ask a doctor if condition gets worse symptoms last for more than 7 days symptoms clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 14 words ▾

Other information store between 20 °C and 25 °C (68 °F and 77 °F)

🧪 Active Ingredient 5 words ▾

Active ingredient Lidocaine HCl 4%

🧪 Inactive Ingredients 40 words ▾

Inactive ingredients acrylates/C10-30 alkyl acrylate crosspolymer, aloe barbadensis (aloe vera) leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, edetate disodium, ethylhexylglycerin, glyceryl monostearate, methylparaben, purified water, SD alcohol 40, steareth-21

🎯 Purpose 3 words ▾

Purpose Topical analgesic

📄 Do Not Use 13 words ▾

Do not use in large quantities, particularly over raw surfaces or blistered areas

📄 When Using This Product 9 words ▾

When using this product do not get into eyes

📄 Stop Use and Ask a Doctor If 27 words ▾

Stop use and ask a doctor if condition gets worse symptoms last for more than 7 days symptoms clear up and occur again within a few days

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 39 words ▾

Principal display panel Leader NDC 70000-0098-1 Maximum Strength Lidocaine Pain Relief Cream Lidocaine HCl 4% Topical Analgesic Non Greasy Compare to aspercreme lidocaine cream active ingredient 100% Money Back Guarantee Net wt 2.7 oz (76.5g) Front Label Carton Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
15.6K
Units reimbursed last 4 qtrs
1.1M
Gross reimbursed last 4 qtrs
$128.9K
Avg / prescription
$8.28
Avg / unit
$0.1122
Latest quarter Q1 2026
6KRx
Medicaid pays / g
$0.1122
gross reimbursed
vs
NADAC / g
$0.0521
acquisition cost
=
Spread
+$0.0601
+115% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
96% FFS
Fee-for-service · 14,963 Rx Managed care · 612 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 1,103,418 units · 5,638 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: 16,398 units · 127 per 100k residents PA New Jersey: 8,721 units · 93.9 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 2,110 units · 46.6 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 18,131 units · 244 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
46.65,638
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 5,638 /100k
2 Arizona 244 /100k
3 Pennsylvania 127 /100k
4 New Jersey 93.9 /100k
5 Kentucky 46.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Lidocaine HCl Viscous (matched by generic name) — the program that covers self-administered drugs. 4 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Lidocaine HCl Viscous. CMS lists 5 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$2.02M
Claims incl. refills
110.4K
Beneficiaries
87.1K
Spend / beneficiary
$23.19
Spend / claim
$18.30
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 70000-0097-01 · Cardinal 70000-0099-01 · CARDINAL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.